Skip to content

Bain Capital Public Equity Management II, LLC

Follow

13F filer, CIK 1768111, BOSTON, MA

Bain Capital Public Equity Management II, LLC reported $0 across 1 holding for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-461919

Period
2026-09-30
Reported value
$0
Holdings
1
Top 10 weight
New
0
Sold out
0

Part of the filer group Bain Capital Life Sciences Investors, LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • SGRY SURGERY PARTNERS INC: 13D/A 30,055,197 shares, 22.96% of the class, 13D/A filed 2026-10-26, 0001193125-26-431228Timeline
    Accepted , ingested
  • ADCT ADC THERAPEUTICS SA: 13G 14,825,625 shares, 9.99% of the class, 13G filed 2026-10-29, 0001193125-26-438199Timeline
    Accepted , ingested

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-461919, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 0 shares; 2026Q2: 0 shares; 2026Q3: 0 shares 0$00Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-461919 base2026-11-16